Dr Yan Li PhD
Senior Postdoctoral Fellow
Current AppointmentsKinghorn Chair, Neurodegeneration
Key Research Areas
Professor Carolyn Sue, MBBS, PhD, FRACP, is an internationally recognised clinician-scientist, a leader in Parkinson’s and mitochondrial disease and a medicine alum of UNSW who trained at Prince of Wales Hospital and at Columbia University in the United States.
Professor Sue was the head of the Departments of Neurogenetics and Neurology at Northern Sydney Local Health District, while also leading Royal North Shore Hospital’s clinic for Mitochondrial disease patients – the largest Mitochondrial disease clinic in Australia. She is the immediate past Executive Director of the Kolling Institute, where she positioned the institute as a centre of world-leading translational research excellence.
Carolyn’s experience, expertise and contribution have been widely recognised. She is a Fellow of the Australian Academy of Health and Medical Sciences and serves on the Council of the National Health and Medical Research Council. She also holds leadership roles at Movement Disorder Society of Australia and New Zealand, International Parkinson’s disease and Movement Disorder Society, the Mito Foundation and Australian Mitochondrial Disease Medical Network. In 2019, Carolyn was awarded a member of the Order of Australia (AM) in recognition of her significant services to medicine, particularly mitochondrial disease.
2023, 03 Jan
Author Response: Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis
View full journal-article on https://doi.org/10.1212/WNL.0000000000201677
Decompensation of cardiorespiratory function and emergence of anemia during pregnancy in a case of mitochondrial myopathy, lactic acidosis, and sideroblastic anemia 2 with compound heterozygous YARS2 pathogenic variants
View full journal-article on https://doi.org/10.1002/ajmg.a.62755
2022, 21 Mar
Mitochondrial donation: is Australia ready?
View full journal-article on https://doi.org/10.5694/mja2.51309
The impact of device-assisted therapies on the gut microbiome in Parkinson’s disease
View full journal-article on https://doi.org/10.1007/s00415-021-10657-9
Patient care standards for primary mitochondrial disease in Australia: an Australian adaptation of the Mitochondrial Medicine Society recommendations
View full journal-article on https://doi.org/10.1111/imj.15505
2021, 11 Nov
NEMoE: A nutrition aware regularized mixture of experts model addressing diet-cohort heterogeneity of gut microbiota in Parkinson’s disease
View full preprint on https://doi.org/10.1101/2021.11.10.21266194
Every dollar of community support enables our scientists to continue making life-changing discoveries that contribute to a brighter and healthier future.
Run, swim or bake your way to making a positive difference in the lives of people touched by brain and nervous system disorders.